Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia | NEJM
Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis through ex vivo clustered regularly interspaced short palindromic repeats (CRISPR)–Ca…